489 related articles for article (PubMed ID: 31693212)
1. Maternal acetaminophen use during pregnancy and childhood behavioural problems: Discrepancies between mother- and teacher-reported outcomes.
Parker SE; Collett BR; Werler MM
Paediatr Perinat Epidemiol; 2020 May; 34(3):299-308. PubMed ID: 31693212
[TBL] [Abstract][Full Text] [Related]
2. Associations of prenatal or infant exposure to acetaminophen or ibuprofen with mid-childhood executive function and behaviour.
Rifas-Shiman SL; Cardenas A; Hivert MF; Tiemeier H; Bertoldi AD; Oken E
Paediatr Perinat Epidemiol; 2020 May; 34(3):287-298. PubMed ID: 31637744
[TBL] [Abstract][Full Text] [Related]
3. Low neurodevelopmental performance and behavioural/emotional problems at 24 and 48 months in Brazilian children exposed to acetaminophen during foetal development.
Tovo-Rodrigues L; Carpena MX; Martins-Silva T; Santos IS; Anselmi L; Barros AJD; Barros FC; Bertoldi AD; Matijasevich A
Paediatr Perinat Epidemiol; 2020 May; 34(3):278-286. PubMed ID: 32196712
[TBL] [Abstract][Full Text] [Related]
4. Prenatal paracetamol exposure and neurodevelopmental outcomes in preschool-aged children.
Trønnes JN; Wood M; Lupattelli A; Ystrom E; Nordeng H
Paediatr Perinat Epidemiol; 2020 May; 34(3):247-256. PubMed ID: 31448449
[TBL] [Abstract][Full Text] [Related]
5. Pre-pregnancy body mass index and parent and teacher-reported behavioral outcomes among offspring in childhood.
Parker SE; Carlson JM; Kebede N; Werler MM; Janulewicz PA
Neurotoxicol Teratol; 2022; 89():107049. PubMed ID: 34780987
[TBL] [Abstract][Full Text] [Related]
6. Associations between paracetamol (acetaminophen) intake between 18 and 32 weeks gestation and neurocognitive outcomes in the child: A longitudinal cohort study.
Golding J; Gregory S; Clark R; Ellis G; Iles-Caven Y; Northstone K
Paediatr Perinat Epidemiol; 2020 May; 34(3):257-266. PubMed ID: 31523834
[TBL] [Abstract][Full Text] [Related]
7. Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding.
Stergiakouli E; Thapar A; Davey Smith G
JAMA Pediatr; 2016 Oct; 170(10):964-970. PubMed ID: 27533796
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to acetaminophen and adolescent assessment of behavior: Discrepancies by age and reporter.
Smith-Webb RS; Barnard-Mayers R; Werler MM; Parker SE
Front Pharmacol; 2023; 14():1084781. PubMed ID: 36937866
[TBL] [Abstract][Full Text] [Related]
9. Associations of acetaminophen use during pregnancy and the first year of life with neurodevelopment in early childhood.
Bertoldi AD; Rifas-Shiman SL; Boing AC; da Silva Dal Pizzol T; Miranda VIA; Silveira MPT; Freitas Silveira M; Domingues MR; Santos IS; Bassani DG; Tovo-Rodrigues L; Oken E
Paediatr Perinat Epidemiol; 2020 May; 34(3):267-277. PubMed ID: 31965601
[TBL] [Abstract][Full Text] [Related]
10. Preconception and prenatal cannabis use and the risk of behavioural and emotional problems in the offspring; a multi-informant prospective longitudinal study.
El Marroun H; Bolhuis K; Franken IHA; Jaddoe VWV; Hillegers MH; Lahey BB; Tiemeier H
Int J Epidemiol; 2019 Feb; 48(1):287-296. PubMed ID: 30239742
[TBL] [Abstract][Full Text] [Related]
11. Prenatal triptan exposure and neurodevelopmental outcomes in 5-year-old children: Follow-up from the Norwegian Mother and Child Cohort Study.
Harris GE; Wood M; Ystrom E; Nordeng H
Paediatr Perinat Epidemiol; 2018 May; 32(3):247-255. PubMed ID: 29569251
[TBL] [Abstract][Full Text] [Related]
12. Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.
Grzeskowiak LE; Morrison JL; Henriksen TB; Bech BH; Obel C; Olsen J; Pedersen LH
BJOG; 2016 Nov; 123(12):1919-1928. PubMed ID: 26374344
[TBL] [Abstract][Full Text] [Related]
13. Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported Outcomes.
Inoue K; Ritz B; Ernst A; Tseng WL; Yuan Y; Meng Q; Ramlau-Hansen CH; Strandberg-Larsen K; Arah OA; Obel C; Li J; Olsen J; Liew Z
Am J Epidemiol; 2021 Jun; 190(6):1009-1020. PubMed ID: 33230558
[TBL] [Abstract][Full Text] [Related]
14. Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study.
Wood ME; Lapane K; Frazier JA; Ystrom E; Mick EO; Nordeng H
Paediatr Perinat Epidemiol; 2016 Mar; 30(2):190-200. PubMed ID: 26525300
[TBL] [Abstract][Full Text] [Related]
15. Upper respiratory infection during pregnancy and neurodevelopmental outcomes among offspring.
Parker SE; Lijewski VA; Janulewicz PA; Collett BR; Speltz ML; Werler MM
Neurotoxicol Teratol; 2016; 57():54-59. PubMed ID: 27343815
[TBL] [Abstract][Full Text] [Related]
16. Developmental cascades of internalising symptoms, externalising problems and cognitive ability from early childhood to middle adolescence.
Flouri E; Papachristou E; Midouhas E; Ploubidis GB; Lewis G; Joshi H
Eur Psychiatry; 2019 Apr; 57():61-69. PubMed ID: 30677550
[TBL] [Abstract][Full Text] [Related]
17. Preadolescent behavior problems after prenatal cocaine exposure: Relationship between teacher and caretaker ratings (Maternal Lifestyle Study).
Bada HS; Bann CM; Bauer CR; Shankaran S; Lester B; LaGasse L; Hammond J; Whitaker T; Das A; Tan S; Higgins R
Neurotoxicol Teratol; 2011; 33(1):78-87. PubMed ID: 20600844
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study.
Wood ME; Frazier JA; Nordeng HM; Lapane KL
BMJ Open; 2016 Sep; 6(9):e011971. PubMed ID: 27625061
[TBL] [Abstract][Full Text] [Related]
19. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort.
Batstra L; Hadders-Algra M; Neeleman J
Early Hum Dev; 2003 Dec; 75(1-2):21-33. PubMed ID: 14652157
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children.
Markovic M; Swanson SA; Stricker BH; Jaddoe VWV; Verhulst FC; Tiemeier H; El Marroun H
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):452-459. PubMed ID: 30838712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
